A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.
Rachel Orr
Advertisement
GSK, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK
Articles by Rachel Orr
Advertisement
Latest Updated Articles
Risk-Based Predictive Stability–An Industry PerspectivePublished: March 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Frankfurt 2025: Regulatory Challenges for Global Manufacturing of Vaccines
2
AI and Accelerated Computing Propel the Biopharma Ecosystem Forward
3
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
4
Thermo Fisher Launches OpenAI Partnership at CPHI Frankfurt 2025: Part One
5
